St. John's Wort for Depression: Evidence, Risks, and Clinical Guidance

Hypericum perforatum (St. John's Wort) is widely used for mild depression, but evidence is mixed and risks are significant.

Evidence Summary

  • Mild–moderate depression: Some meta-analyses show superiority over placebo, comparable to SSRIs (short-term, 4–12 weeks).
  • Severe depression: Insufficient evidence; not recommended as monotherapy.
  • Long-term (>12 weeks): Limited data; relapse rates unclear.
  • Quality concerns: Studies vary in extract standardization (hypericin vs. hyperforin), dose, duration.

Mechanism (Proposed)

Inhibits reuptake of serotonin, dopamine, norepinephrine; modulates GABA/glutamate; anti-inflammatory. Similar to conventional antidepressants but multi-target.

Critical Safety Concerns

Regulatory Status

  • U.S.: Dietary supplement (DSHEA)—no FDA efficacy review; quality varies.
  • Germany: Licensed phytomedicine (standardized extracts, prescription for moderate depression).
  • Other EU: Varies; some restrict OTC sales.

Clinical Recommendations

  1. Do not self-medicate for depression—diagnosis requires professional evaluation.
  2. Disclose all supplements to every provider (including surgeons, pharmacists).
  3. If considering: Choose standardized extract (0.3% hypericin, 3–5% hyperforin), 300 mg TID, from reputable brand (USP/NSF verified).
  4. Monitor: Mood, side effects, drug levels if on interacting meds.
  5. First-line for mild depression: Psychotherapy (CBT), exercise, sleep hygiene—evidence stronger, risks lower.
  6. Bottom line: St. John's Wort has biological activity but unpredictable quality and dangerous interactions. It is not a safe substitute for evidence-based depression treatment.

    Depression - Related Articles

    Health Sciences © https://www.222health.com

RiskDetails
Drug InteractionsInduces CYP3A4 & P-glycoprotein → reduces levels of: oral contraceptives, warfarin, cyclosporine, digoxin, theophylline, HIV protease inhibitors, some chemo, SSRIs (serotonin syndrome risk). 200+ documented interactions.
PhotosensitivityIncreased sunburn risk; use SPF 30+
Side EffectsGI upset, dizziness, dry mouth, fatigue, sexual dysfunction (similar to SSRIs)
Pregnancy/LactationInsufficient safety data; avoid
SurgeryDiscontinue 2–3 weeks prior (bleeding risk, anesthesia interactions)